Maintenance of skeletal muscle mass during FOLFIRINOX is a favorable prognostic factor in pancreatic cancer patients

被引：0
|
作者：
Dong Woo Shin
Minseok Albert Kim
Jong-chan Lee
Jaihwan Kim
Jin-Hyeok Hwang
机构：
[1] Seoul National University College of Medicine,Department of Internal Medicine
[2] Seoul National University Bundang Hospital,Division of Gastroenterology, Department of Internal Medicine
[3] Keimyung University School of Medicine,Department of Internal Medicine
[4] Keimyung University Dongsan Medical Center,undefined
[5] Seoul National University College of Medicine,undefined
[6] Seoul National University Hospital,undefined
来源：
BMC Research Notes | / 14卷
关键词：
Locally advanced pancreatic cancer; Skeletal muscle; Adipose tissue; Prognosis; FOLFIRINOX;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Maintenance of skeletal muscle mass during FOLFIRINOX is a favorable prognostic factor in pancreatic cancer patients
    Shin, Dong Woo
    Kim, Minseok Albert
    Lee, Jong-chan
    Kim, Jaihwan
    Hwang, Jin-Hyeok
    BMC RESEARCH NOTES, 2021, 14 (01)
  • [2] THE IMPACT OF SKELETAL MUSCLE MASS LOSS IN PATIENTS WITH ADVANCED PANCREATIC CANCER DURING FOLFIRINOX
    Uemura, Shinya
    Iwashita, Takuji
    Ichikawa, Hironao
    Iwasa, Yuhei
    Mita, Naoki
    Shimizu, Masahito
    GASTROENTEROLOGY, 2020, 158 (06) : S863 - S863
  • [3] The impact of sarcopenia and decrease in skeletal muscle mass in patients with advanced pancreatic cancer during FOLFIRINOX therapy
    Uemura, Shinya
    Iwashita, Takuji
    Ichikawa, Hironao
    Iwasa, Yuhei
    Mita, Naoki
    Shiraki, Makoto
    Shimizu, Masahito
    BRITISH JOURNAL OF NUTRITION, 2021, 125 (10) : 1140 - 1147
  • [4] Skeletal muscle mass as a prognostic indicator in resected pancreatic cancer patients
    Jongchan, Lee
    Jong-Chan, Lee
    In-Kuk, Cho
    Jaihwan, Kim
    Jin-Hyeok, Hwang
    ANNALS OF ONCOLOGY, 2017, 28
  • [5] Early loss of skeletal muscle mass (LSMM) as prognostic factor in metastatic pancreatic cancer (PC) patients
    Basile, D.
    Parnofiello, A.
    Vitale, M. G.
    Cortiula, F.
    Garattini, S. K.
    Gerratana, L.
    Andreotti, V. J.
    Ongaro, E.
    Lisanti, C.
    Bartoletti, M.
    Bonotto, M.
    Fanotto, V.
    Cattaneo, M.
    Iacono, D.
    Bacco, A.
    Ermacora, P.
    Puglisi, F.
    Aprile, G.
    Pella, N.
    Cardellino, G. G.
    Fasola, G.
    ANNALS OF ONCOLOGY, 2017, 28
  • [6] Effect on survival of skeletal muscle mass changes in patients with locally advanced pancreatic cancer receiving FOLFIRINOX
    Kim, Minseok Albert
    Lee, Jongchan
    Lee, Jong-Chan
    Cho, In Kuk
    Kim, Jaihwan
    Hwang, Jin-Hyeok
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 534 - 534
  • [7] EFFECT ON SURVIVAL OF SKELETAL MUSCLE MASS CHANGES IN PATIENTS WITH LOCALLY ADVANCED PANCREATIC CANCER RECEIVING FOLFIRINOX
    Kim, Minseok A.
    Lee, Jongchan
    Lee, Jong-chan
    Cho, In Kuk
    Kim, Jaihwan
    Hwang, Jin-Hyeok
    GASTROENTEROLOGY, 2018, 154 (06) : S940 - S940
  • [8] Postoperative muscle mass restoration as a prognostic factor in patients with resected pancreatic cancer
    Lee, Jongchan
    Lee, Jong-chan
    Kim, Hyoung Woo
    Kim, Jaihwan
    Hwang, Jin-Hyeok
    PLOS ONE, 2020, 15 (09):
  • [9] Loss of skeletal muscle mass during palliative chemotherapy is a poor prognostic factor in patients with advanced gastric cancer
    Hwang, I. G.
    Park, S. E.
    Lee, S-C.
    Choi, J. H.
    ANNALS OF ONCOLOGY, 2019, 30 : 727 - 727
  • [10] Loss of skeletal muscle mass during palliative chemotherapy is a poor prognostic factor in patients with advanced gastric cancer
    Song Ee Park
    Jin Hwa Choi
    Jae Yong Park
    Beom Jin Kim
    Jae Gyu Kim
    Jong Won Kim
    Joong-Min Park
    Kyong-Choun Chi
    In Gyu Hwang
    Scientific Reports, 10
12345